Nutriband Net Income From Continuing Ops from 2010 to 2024

NTRB Stock  USD 4.75  0.06  1.25%   
Nutriband's Net Loss is decreasing over the years with slightly volatile fluctuation. Overall, Net Loss is projected to go to about -5.2 M this year. From 2010 to 2024 Nutriband Net Loss quarterly data regression line had arithmetic mean of (2,212,911) and slope of (477,869). View All Fundamentals
 
Net Loss  
First Reported
2017-01-31
Previous Quarter
-1.9 M
Current Value
-1.7 M
Quarterly Volatility
876.2 K
 
Covid
Check Nutriband financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Nutriband's main balance sheet or income statement drivers, such as Discontinued Operations of 0.0, Interest Expense of 68 K or Selling General Administrative of 2.4 M, as well as many indicators such as Price To Sales Ratio of 9.46, Dividend Yield of 0.0053 or PTB Ratio of 3.39. Nutriband financial statements analysis is a perfect complement when working with Nutriband Valuation or Volatility modules.
  
Check out the analysis of Nutriband Correlation against competitors.
For information on how to trade Nutriband Stock refer to our How to Trade Nutriband Stock guide.

Latest Nutriband's Net Income From Continuing Ops Growth Pattern

Below is the plot of the Net Income From Continuing Ops of Nutriband over the last few years. It is Nutriband's Net Loss historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Nutriband's overall financial position and show how it may be relating to other accounts over time.
Net Income From Continuing Ops10 Years Trend
Slightly volatile
   Net Income From Continuing Ops   
       Timeline  

Nutriband Net Income From Continuing Ops Regression Statistics

Arithmetic Mean(2,212,911)
Coefficient Of Variation(105.50)
Mean Deviation2,041,375
Median(2,671,946)
Standard Deviation2,334,575
Sample Variance5.5T
Range6.2M
R-Value(0.92)
Mean Square Error951B
R-Squared0.84
Slope(477,869)
Total Sum of Squares76.3T

Nutriband Net Income From Continuing Ops History

2024-5.2 M
2023-5.5 M
2022-4.5 M
2021-6.2 M
2020-2.9 M
2019-2.7 M
2018-3.3 M

About Nutriband Financial Statements

Nutriband stakeholders use historical fundamental indicators, such as Nutriband's Net Income From Continuing Ops, to determine how well the company is positioned to perform in the future. Although Nutriband investors may analyze each financial statement separately, they are all interrelated. For example, changes in Nutriband's assets and liabilities are reflected in the revenues and expenses on Nutriband's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Nutriband. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Net Loss-5.5 M-5.2 M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
When determining whether Nutriband offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Nutriband's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Nutriband Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Nutriband Stock:
Check out the analysis of Nutriband Correlation against competitors.
For information on how to trade Nutriband Stock refer to our How to Trade Nutriband Stock guide.
You can also try the Portfolio Volatility module to check portfolio volatility and analyze historical return density to properly model market risk.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Nutriband. If investors know Nutriband will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Nutriband listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(0.80)
Revenue Per Share
0.243
Quarterly Revenue Growth
(0.14)
Return On Assets
(0.30)
Return On Equity
(0.60)
The market value of Nutriband is measured differently than its book value, which is the value of Nutriband that is recorded on the company's balance sheet. Investors also form their own opinion of Nutriband's value that differs from its market value or its book value, called intrinsic value, which is Nutriband's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Nutriband's market value can be influenced by many factors that don't directly affect Nutriband's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Nutriband's value and its price as these two are different measures arrived at by different means. Investors typically determine if Nutriband is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Nutriband's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.